FindMyRecallSubscribe
Class I: serious health riskOngoing

Apotex Enoxaparin Sodium Injection Recall

Enoxaparin Sodium Injection, USP 100 mg/mL Single Dose Syringes with Automatic Safety D…

Apotex Corp. · Weston, FL

Risk level
Class I
Reported by FDA
Feb 17, 2021
Recall ID
D-0261-2021
Check your lot numberHow we source this data

Summary

Apotex recalled Enoxaparin Sodium Injection starting Feb 2, 2021. The FDA classified it as Class I (serious health risk) and published enforcement report D-0261-2021 on Feb 17, 2021. Reason: Labeling; Label Mixup; syringe barrels may containing markings for 150 mg/mL (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings (corresponding to 100 mg/mL strength). Status: Ongoing.

Why it was recalled

Labeling; Label Mixup; syringe barrels may containing markings for 150 mg/mL (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings (corresponding to 100 mg/mL strength)

Product description

Enoxaparin Sodium Injection, USP 100 mg/mL Single Dose Syringes with Automatic Safety Device For Subcutaneous Injection 10 x 1 mL Single Dose Syringes Rx Only, Manufactured by: Gland Pharma Ltd. Hyderabad, India Manufactured for: Apotex Corp. Weston, FL 33326 NDC 60505-0795-4 UPC 360505079544 (carton) NDC 60505-0795-1 UPC (01)10360505079510 (label)

Lot numbers, UPCs & expiration codes

Batch: CS008 Exp. 04/2022

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0261-2021
Classification
Class I
Status
Ongoing
Recall initiated
Feb 2, 2021
FDA report date
Feb 17, 2021
Quantity
6670 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Corp.

Original FDA data

Every field from FDA enforcement report D-0261-2021, exactly as published.

Show all FDA fields
City
Weston
State
FL
Status
Ongoing
Country
United States
Event ID
87269
Address
2400 N Commerce Pkwy Ste 400
Code information
Batch: CS008 Exp. 04/2022
Postal code
33326-3253
Report date
Feb 17, 2021
Product type
Drugs
Recall number
D-0261-2021
Classification
Class I
Recalling firm
Apotex Corp.
Product quantity
6670 cartons
Reason for recall
Labeling; Label Mixup; syringe barrels may containing markings for 150 mg/mL (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings (corresponding to 100 mg/mL strength)
Voluntary / mandated
Voluntary: Firm initiated
Product description
Enoxaparin Sodium Injection, USP 100 mg/mL Single Dose Syringes with Automatic Safety Device For Subcutaneous Injection 10 x 1 mL Single Dose Syringes Rx Only, Manufactured by: Gland Pharma Ltd. Hyderabad, India Manufactured for: Apotex Corp. Weston, FL 33326 NDC 60505-0795-4 UPC 360505079544 (carton) NDC 60505-0795-1 UPC (01)10360505079510 (label)
Distribution pattern
Nationwide
Recall initiation date
Feb 2, 2021
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Feb 17, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0261-2021, published Feb 17, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls